Member Info for alarno

I tried to order through a Superdrug clinic. Work through the process and you will see it

Having to pay for a blood test before you can see the appointments available is a draw back. If people are time sensitive it will put them off.

Brilliant update. The threads that George mentioned were so encouraging. Very good

London Medical Labs now have 86 clinics of their own.

No. I think that went to Dragonfly

Its no surprise. It was one of the questions put to Marc. We are still selling. Did, however, sell the plant for the same value as our current market cap. Smart move

https://www.investegate.co.uk/goodbody-health-ltd--gdby-/rns/divestment-of-polish-cbd-operations/202212160700049181J/

Selling up on cbd.....

https://www.bbc.co.uk/news/health-63331805?
at_medium=RSS&at_campaign=KARANGA

He referred to crossing paths soon with the NHS. I have previously posted this link. I think we will play a part in the trials

Apparently, you are right. It is to reduce operating costs. Its not just Marc to go. Others have gone with him

Marc has resigned with immediate effect. Not a good sign at all.

Current assets are £3.9 m. 3 times the current share price

Nothing wrong with the business. Its the share price at £1.3m market cap that is out of sorts. We all know the business is worth much more than that.

https://businesscann.com/european-cannabis-stocks-review-intercure-up-10-amid-more-record-results-stenocare-secures-new-funding-more-from-goodbody-health/

No. They will always email shareholders after an announcement. I may have subscribed to this early on. I will pass on anything relevant.

Marc has stated that they don't need money and that they have a war chest to roll out the strategy. The email to investors may tell us more when it lands today.

Goodbody Health turns focus to preventative diagnostics
03:15 Fri 11 Nov 2022
Jai Singh
View
Goodbody Health Ltd
AQSE:GDBY
OTCQB:GDBYF
Goodbody Health Ltd - Goodbody Health turns focus to preventative diagnostics
Goodbody Health Ltd (AQSE:GDBY, OTCQB:GDBYF) said its focus is now on preventative diagnostics as it looks to become a “leading aggregator” of innovative technology and tests.

The health diagnostics firm said in a third-quarter trading update that it will focus on blood and genetic testing alongside other services at its 258 clinics, including ear wax removal.

“The range of opportunities to develop our proposition in this exciting growth market to support the NHS and help people have better health outcomes are very exciting,” said chief executive Marc Howells.

“This direction of travel is one we embrace and look forward to delivering in the post-covid UK."

In the nine months to 30 September 2022, the AQSE Growth Market-listed company said revenue fell 6% compared to 2021 to £9.29mln, largely due to reduced but ongoing Covid testing delaying the roll-out of other tests.

Gross profit in the year-to-date also slipped 16% to £4.46mln, “reflecting the competitive environment”, a statement said.

As a result, it said the expected outcome for the end of the year will be lower than anticipated due to the current economic client, a squeeze on consumer spending and lead time for new products.

3rd quarter results are out. We now have 258 clinics and more products on the way. Dip in gross profit as predicted.

Allied have 50+ pharmacies. We are only in 17 at the minute. Same with Superdrug. Lots of scope everywhere....

The share price is effectively at rock bottom. It cannnot get any worse. Unless of course they go bust.

Take heart from the fact that they are signing deals with major players in the market . They have a massive potential market with more products coming online soon and they are expanding all the time with their own money.

One day this share price will explode but it will not be over night. It maybe years before I get my money back, if at all.

Geremy asked the long term holders to hang in there. Long term holders are only too familiar with this sitution. Its rough going but its an exciting business that we are invested in. Enjoy yor day Lebad, things will get better.

That puts the market cap at below £2m now by my reckoning. Share price is out of sink with whats going on in the business.